Salvato in:
| Autori principali: | Fang Huang, Ke Cui, Jie Zhao, Zhichao Li, Yun Qin, Siguo Hao, Jiangbo Wan |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2026
|
| Soggetti: | |
| Accesso online: | https://onlinelibrary.wiley.com/doi/10.1002/jca.70091 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Cost‐Effectiveness of Preemptive Plerixafor Versus Rescue Plerixafor for Mobilization and Collection of Hematopoietic Stem Cells in Patients With Multiple Myeloma and Lymphoma
di: Roselene Mesquita Augusto Passos, et al.
Pubblicazione: (2025)
di: Roselene Mesquita Augusto Passos, et al.
Pubblicazione: (2025)
Poor Mobilization and Plerixafor Use in Matched Related Peripheral Hematopoietic Progenitor Cell Donors
di: Elizabeth A. Godbey, et al.
Pubblicazione: (2025)
di: Elizabeth A. Godbey, et al.
Pubblicazione: (2025)
Safety and Efficacy of DPMAS in Patients With Acute‐on‐Chronic Liver Failure Based on Different Platelet Count Levels
di: Lingyun Niu, et al.
Pubblicazione: (2025)
di: Lingyun Niu, et al.
Pubblicazione: (2025)
Optimizing autologous stem cell collections for patients with multiple myeloma receiving G‐CSF and Plerixafor: A single center project
di: Ayda Javanbakht, et al.
Pubblicazione: (2024)
di: Ayda Javanbakht, et al.
Pubblicazione: (2024)
Preemptive Approach to Plerixafor Use Is Optimal in Patients With Relapsed/Refractory Germ Cell Tumors Undergoing Peripheral Blood Hematopoietic Stem Cell Collection: Effect on Collection Days, Yields, and Cost
di: David O. Sohutskay, et al.
Pubblicazione: (2024)
di: David O. Sohutskay, et al.
Pubblicazione: (2024)
Chemo‐Mobilization Using Modified PACE Regimens in Multiple Myeloma Patients
di: Laura Cooling, et al.
Pubblicazione: (2025)
di: Laura Cooling, et al.
Pubblicazione: (2025)
A Single‐Center Retrospective Study Evaluating the Role of Therapeutic Plasma Exchange in Patients With an Initial Diagnosis of Optic Neuritis
di: Mishi Bhushan, et al.
Pubblicazione: (2025)
di: Mishi Bhushan, et al.
Pubblicazione: (2025)
Mobilization and Apheresis Collection Strategies to Reduce Platelet Loss in G‐CSF Mobilized Healthy Adult Donors
di: Brittany Castro, et al.
Pubblicazione: (2024)
di: Brittany Castro, et al.
Pubblicazione: (2024)
Efficacy and Safety of Using Designed Auxiliary Lines in Standard CRRT Machines for DFPP Treatment
di: Fang Wang, et al.
Pubblicazione: (2025)
di: Fang Wang, et al.
Pubblicazione: (2025)
Exposure to Shower Water Without Dressings Is Associated With Increased Risk of Catheter‐Related Infection in Peritoneal Dialysis Patients: A Retrospective Cohort Study
di: Shingo Urate, et al.
Pubblicazione: (2026)
di: Shingo Urate, et al.
Pubblicazione: (2026)
A Review of the Scope of Dual Coping Interventions for Hemodialysis Patients and Caregivers
di: Wan Li, et al.
Pubblicazione: (2025)
di: Wan Li, et al.
Pubblicazione: (2025)
Optimal Timing of Therapeutic Plasma Exchange and Hepatic Encephalopathy Severity as Predictors of Clinical Outcome in Liver Failure: A Retrospective Observational Study
di: Juilee Shalik Charmode, et al.
Pubblicazione: (2026)
di: Juilee Shalik Charmode, et al.
Pubblicazione: (2026)
The Safety and Efficacy of Regional Citrate Anticoagulation in Therapeutic Plasma Exchange: A Systematic Review and Meta‐Analysis
di: Tong Liu, et al.
Pubblicazione: (2025)
di: Tong Liu, et al.
Pubblicazione: (2025)
Comparison of Peripheral Stem Cell Mobilization Results on the Fourth and Fifth Day of G‐CSF Treatment in Unrelated Donors
di: Gulten Korkmaz, et al.
Pubblicazione: (2026)
di: Gulten Korkmaz, et al.
Pubblicazione: (2026)
Efficacy Comparison of Centrifugation Filtration Plasmapheresis and Plasma Exchange in Hyperlipidemic Acute Pancreatitis Patients
di: Dongmei Yang, et al.
Pubblicazione: (2025)
di: Dongmei Yang, et al.
Pubblicazione: (2025)
Safety and Efficacy of Low‐Volume Plasma Exchange in the Management of COVID‐19‐ Associated Guillain‐Barré Syndrome: A Case Report
di: Vjeroslava Slavic, et al.
Pubblicazione: (2026)
di: Vjeroslava Slavic, et al.
Pubblicazione: (2026)
Efficacy of Combined Plasma Exchange With Plasma Adsorption/Hemoperfusion Artificial Liver Support System ( ALSS ) in Treating Acute‐on‐Chronic Liver Failure due to Hepatitis B
di: Dingchun Li, et al.
Pubblicazione: (2026)
di: Dingchun Li, et al.
Pubblicazione: (2026)
Citrate Versus Citrate–Heparin Anticoagulation in HPC (A): Comparative Effects on Intra‐Apheresis Mobilization of CD34 + Hematopoietic Progenitor Cells
di: Yandy Marx Castillo‐Aleman, et al.
Pubblicazione: (2026)
di: Yandy Marx Castillo‐Aleman, et al.
Pubblicazione: (2026)
Initial Symptom Duration Among Vulnerable Dialysis Patients Hospitalized for Long‐Term Care Correlates With Post‐ COVID ‐19 Poor Prognosis
di: Takayuki Hirai, et al.
Pubblicazione: (2026)
di: Takayuki Hirai, et al.
Pubblicazione: (2026)
Limited Utility of Serum Hepcidin as a Marker for Erythropoiesis‐Stimulating Agent Hyporesponsiveness in Hemodialysis Patients: An Analysis From the INFINITY Cohort
di: Tomomi Matsuoka, et al.
Pubblicazione: (2025)
di: Tomomi Matsuoka, et al.
Pubblicazione: (2025)
Cell‐Free and Concentrated Ascites Reinfusion Therapy ( CART ) Shows Enhanced Efficacy in Gynecological Cancer Patients: A Post‐Marketing Surveillance Study
di: Nami Tamura, et al.
Pubblicazione: (2025)
di: Nami Tamura, et al.
Pubblicazione: (2025)
Comparison of Clinical Efficacy of Low‐Site Catheter Placement With Long‐Segment Rectus Abdominis Embedding Versus Conventional Peritoneal Dialysis Catheter Placement
di: Sha Chen, et al.
Pubblicazione: (2025)
di: Sha Chen, et al.
Pubblicazione: (2025)
Advances in Research on Risk Factors and Development of Risk Prediction Models for Cognitive Frailty in Maintenance Hemodialysis Patients
di: Duo Wang, et al.
Pubblicazione: (2025)
di: Duo Wang, et al.
Pubblicazione: (2025)
Plasmapheresis in Low Body Weight Infant With Acute Liver Failure
di: Katja Kimberger, et al.
Pubblicazione: (2026)
di: Katja Kimberger, et al.
Pubblicazione: (2026)
G‐CSF Only Versus Chemotherapy and G‐CSF Peripheral Blood Stem Cell Mobilization for Autologous Hematopoietic Stem Cell Transplant—Assessing a Change in Regime due to the COVID‐19 Pandemic
di: Julia S. Wolf, et al.
Pubblicazione: (2025)
di: Julia S. Wolf, et al.
Pubblicazione: (2025)
Therapeutic Plasma Exchange in Thailand: A 10‐Year Retrospective Analysis
di: Kornchanok Vareesangthip, et al.
Pubblicazione: (2026)
di: Kornchanok Vareesangthip, et al.
Pubblicazione: (2026)
Therapeutic Plasma Exchange to Reverse Plasma Failure in Multiple Organ Dysfunction Syndrome
di: Matthew J. Foglia, et al.
Pubblicazione: (2024)
di: Matthew J. Foglia, et al.
Pubblicazione: (2024)
Efficacy of apheresis in antibody‐negative progressive encephalomyelitis with rigidity and myoclonus
di: Yohei Aoki, et al.
Pubblicazione: (2025)
di: Yohei Aoki, et al.
Pubblicazione: (2025)
Plasma Exchange as a Therapeutic Modality in Pediatric Acute Liver Failure—Reply to Correspondence
di: Bikrant Bihari Lal, et al.
Pubblicazione: (2025)
di: Bikrant Bihari Lal, et al.
Pubblicazione: (2025)
“Therapeutic Plasma Exchange in Children With Acute Liver Failure: Have Standards Been Deviated?”
di: Jagadeesh Menon, et al.
Pubblicazione: (2025)
di: Jagadeesh Menon, et al.
Pubblicazione: (2025)
The Day Two Advantage: A Retrospective Paired Analysis of Consecutive HPC(A) Collections
di: Yandy Marx Castillo‐Aleman, et al.
Pubblicazione: (2025)
di: Yandy Marx Castillo‐Aleman, et al.
Pubblicazione: (2025)
Immunoabsorption Therapy for Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease: A Retrospective Study
di: Dongxue Wang, et al.
Pubblicazione: (2025)
di: Dongxue Wang, et al.
Pubblicazione: (2025)
Therapeutic Apheresis for Neurological Diseases: A Five‐Year Retrospective Study at a Large Academic Medical Center
di: Yaseen Ali Jamal, et al.
Pubblicazione: (2025)
di: Yaseen Ali Jamal, et al.
Pubblicazione: (2025)
Plasma Exchange in ANCA ‐Associated Vasculitis With Kidney Involvement: Differential Outcomes by Kidney Function in a Colombian Cohort
di: Clara Escorcia‐García, et al.
Pubblicazione: (2026)
di: Clara Escorcia‐García, et al.
Pubblicazione: (2026)
Efficacy of the bicarbonate dialysate with acetate concentrations of 0–0.3 and 3–5: A systematic review and meta‐analysis
di: Takeshi Nakata, et al.
Pubblicazione: (2025)
di: Takeshi Nakata, et al.
Pubblicazione: (2025)
Plasma Exchange for Anti‐ GBM Disease With Dialysis Dependency: A Case Series on Clinical Outcomes and Safety
di: Minoru Sakuragi, et al.
Pubblicazione: (2026)
di: Minoru Sakuragi, et al.
Pubblicazione: (2026)
Real‐World Safety Data From the World Apheresis Association Registry for the Spectra Optia Apheresis System
di: Aaron Haubner, et al.
Pubblicazione: (2025)
di: Aaron Haubner, et al.
Pubblicazione: (2025)
Pediatric Therapeutic Plasma Exchange: Characterization of Practice, Epidemiology, and Safety Profile at a Children's Hospital in the United States
di: Benjamin C. Lee, et al.
Pubblicazione: (2026)
di: Benjamin C. Lee, et al.
Pubblicazione: (2026)
Ferritin to Albumin Ratio Predicts Mortality in Peritoneal Dialysis Patients
di: Dilek Barutcu Atas, et al.
Pubblicazione: (2025)
di: Dilek Barutcu Atas, et al.
Pubblicazione: (2025)
Therapeutic Plasma Exchange Shows Greater Efficacy Than DFPP in Reducing FT3 and FT4 Levels in Thyrotoxicosis due to Amiodarone‐Induced Thyrotoxicosis Type 2
di: Marion Gerbal, et al.
Pubblicazione: (2025)
di: Marion Gerbal, et al.
Pubblicazione: (2025)
Documenti analoghi
-
Cost‐Effectiveness of Preemptive Plerixafor Versus Rescue Plerixafor for Mobilization and Collection of Hematopoietic Stem Cells in Patients With Multiple Myeloma and Lymphoma
di: Roselene Mesquita Augusto Passos, et al.
Pubblicazione: (2025) -
Poor Mobilization and Plerixafor Use in Matched Related Peripheral Hematopoietic Progenitor Cell Donors
di: Elizabeth A. Godbey, et al.
Pubblicazione: (2025) -
Safety and Efficacy of DPMAS in Patients With Acute‐on‐Chronic Liver Failure Based on Different Platelet Count Levels
di: Lingyun Niu, et al.
Pubblicazione: (2025) -
Optimizing autologous stem cell collections for patients with multiple myeloma receiving G‐CSF and Plerixafor: A single center project
di: Ayda Javanbakht, et al.
Pubblicazione: (2024) -
Preemptive Approach to Plerixafor Use Is Optimal in Patients With Relapsed/Refractory Germ Cell Tumors Undergoing Peripheral Blood Hematopoietic Stem Cell Collection: Effect on Collection Days, Yields, and Cost
di: David O. Sohutskay, et al.
Pubblicazione: (2024)